In this context, it has been reported that the majority of IDH-mutant astrocytomas of all grades harbour truncating mutations in ATRX, which are mutually exclusive to 1p/19q codeletion and can be detected by the immunohistochemical loss of ATRX protein [2, 10, 11]. Here, IDH2 is linked to astrocytoma (excluding glioblastoma).